Last reviewed · How we verify
NCT05793918
Percutaneous Electrolysis, Ultrasound-guided Percutaneous Neuromodulation Therapy and Eccentric Exercise in Supraspinatus Tendinopathy.
NA trial testing Therapeutic Percutaneous Electrolysis an neuromodulation in Supraspinatus Tendinitis in 46 participants. Completed in 15 September 2023.
1 August 2023
Quick facts
| Lead sponsor | University of Cadiz |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 46 |
| Start date | 13 March 2023 |
| Primary completion | 1 August 2023 |
| Estimated completion | 15 September 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Therapeutic Percutaneous Electrolysis an neuromodulation
- Conventional group — full drug profile →
Conditions studied
- Supraspinatus Tendinitis — all drugs for Supraspinatus Tendinitis →
Sponsor
University of Cadiz
Who can join
Adults 18 to 65, any sex, with Supraspinatus Tendinitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The supraspinatus muscle tendinopathy show a big impact, however, there is a lack of awareness about the options of the physiotherapist treatment. It is necessary to do studies about effectiveness of therapeutic percutaneous electrolysis and neuromodulation. This technique enables treatment of the tendinopathies. To analyze the effectiveness of therapeutic percutaneou electrolysis and neuromodulation in the treatment of supraspinatus muscle tendinopathy. Single center randomized controlled trial, parallel treatment design. A specialist physician will be diagnosed the supraspinatus muscle tendinopathy. Participants will be randomly assigned to receive treatmen for 4 weeks: percutaneou electrolysis and neuromodulation associated with eccentric exercises or conventional treatment of Physiotherapy with the same eccentric exercises. Both interventions were performed under ultrasound guidance with a portable ultrasound (General Electric LogicE). Data will be collected by a blinded evaluator.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Percutaneous Electrolysis, Percutaneous Peripheral Nerve Stimulation, and Eccentric Exercise for Shoulder Pain and Functionality in Supraspinatus Tendinopathy: A Single-Blind Randomized Clinical Trial.
Góngora-Rodríguez J, Rodríguez-Huguet M, Rodríguez-Almagro D, Martín-Valero R, et al · · 2025 · PMID 40843826 · DOI 10.3390/jfmk10030295
Verify or expand the search:
- PubMed search for NCT05793918
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Supraspinatus Tendinitis
Currently open trials in the same condition.
- NCT07470190 — Anatomical Evaluation of Supraspinatus Through Ultrasonography and Biomechanical Measurements Following Different Combin · NA · recruiting
Other University of Cadiz trials
Trials by the same sponsor.
- NCT07584343 — EMG of Gait Under Dual-Task in Parkinson Desease · completed
- NCT07267468 — Effectiveness of an mHealth Intervention, Based on Rehabilitation and a Personalised Nutrition Plan, in the Recovery and · NA · recruiting
- NCT07251322 — Relationship Between Frailty and Gut Microbiota in Older Adults: An Educational Program for Healthy Aging · completed
- NCT06729138 — Resisted Training in Runners · NA · completed
- NCT06871072 — Telerehabilitation for Multiple Sclerosis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05793918 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Cadiz
- Last refreshed: 23 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05793918.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing